Abstract
Objective Our objective is to demonstrate a method to estimate the probability of a laboratory confirmed COVID19 infection, hospitalization, and death arising from a contact with an individual of unknown infection status.
Methods We calculate the probability of a confirmed infection, hospitalization, and death resulting from a county-level person-contact using available data on current case incidence, secondary attack rates, infectious periods, asymptomatic infections, and ratios of confirmed infections to hospitalizations and fatalities.
Results Among US counties with populations greater than 500,000 people, during the week ending June 13,2020, the median estimate of the county level probability of a confirmed infection is 1 infection in 40,500 person contacts (Range: 10,100 to 586,000). For a 50 to 64 year-old individual, the median estimate of the county level probability of a hospitalization is 1 in 709,000 person contacts (Range: 177,000 to 10,200,000) and the median estimate of the county level probability of a fatality is 1 in 6,670,000 person contacts (Range 1,680,000 to 97,600.000).
Conclusions and Relevance Estimates of the individual probabilities of COVID19 infection, hospitalization and death vary widely but may not align with public risk perceptions. Systematically collected and publicly reported data on infection incidence by, for example, the setting of exposure, type of residence and occupation would allow more precise estimates of probabilities than possible with currently available public data. Calculation of secondary attack rates by setting and better measures of the prevalence of seropositivity would further improve those estimates.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding support
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.